Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis

Selective estrogen receptor modulator (SERM)-associated nonalcoholic fatty liver disease (NAFLD) might be related to treatment efficacy in patients with breast cancer because of circulating estrogen antagonism. The aim of the study was to investigate the relationship between NAFLD and survival outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qiufan, Xu, Fei, Nie, Man, Xia, Wen, Qin, Tao, Qin, Ge, An, Xin, Xue, Cong, Peng, Roujun, Yuan, Zhongyu, Shi, Yanxia, Wang, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616748/
https://www.ncbi.nlm.nih.gov/pubmed/26448028
http://dx.doi.org/10.1097/MD.0000000000001718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616748/
https://www.ncbi.nlm.nih.gov/pubmed/26448028
http://dx.doi.org/10.1097/MD.0000000000001718

Ejemplares similares